newsfilter
← Latest News
GlobeNewswire·

Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit

NEEDHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (NASDAQ:CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies